In late 2013, Congress passed the Drug Quality and Security Act (DQSA) in response to a deadly fungal meningitis outbreak linked to a sterile compounded injectable drug shipped across the country and ...

Joe Cabaleiro is executive director at the Pharmacy Compounding Accreditation Board, a nonprofit dedicated to standards and principles for pharmacy compounding. We asked in a phone interview about the ...

The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

I was stunned to read the uncritical editorial ["Concocting a cure," May 7] lauding the draft Senate bill on pharmacy compounding. The Post's statement that compounding pharmacies engaged in drug ...

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...

BOULDER, Colo. — CordenPharma Colorado (CPC), an Active Pharmaceutical Ingredient (API) manufacturing facility in Boulder, Colorado, announces receipt of approval for the "Potent Compound Safety ...

Once again, the FDA has taken a tough stance against a compound pharmacy with quality-control problems that led to product recalls and concerns over patient safety. In this latest instance, the agency ...

HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Mordor Intelligence recently released comprehensive reports on compounding pharmacy market and pharma manufacturing industry, detailing robust growth ...